Engility wins prime position in US DoD logistics and medical contract

30 October 2018 (Last Updated October 30th, 2018 10:14)

The US Department of Defence (DoD) has awarded a medical and logistics contract with a total ceiling value of $249m to engineering services company Engility Holdings.

Engility wins prime position in US DoD logistics and medical contract
Nuclear, biological, and chemical (NBC) disposal technicians taking part in a training exercise. Credit: US Navy / Photographer’s Mate 2nd Class Jeffrey Lehrberg.

The US Department of Defence (DoD) has awarded a medical and logistics contract with a total ceiling value of $249m to engineering services company Engility Holdings.

The company has been awarded a prime spot on the multiple-award DoD Joint Enterprise Omnibus Program, Engineering, and Technical Support Logistics & Medical contract.

Under the indefinite-delivery indefinite-quantity award, Engility will be responsible for assisting the Joint Program Executive Office (JPEO) for Chemical, Biological, Radiological and Nuclear Defense (CBRND) by functioning as the total lifecycle systems manager for defence programmes with the department.

Engility chief executive officer, chairman and president Lynn Dugle said: “We are very proud to have Engility’s recognised medical and logistics experts contribute to this vital programme that provides mission support to JPEO-CBRND.

“Medical support will include product concept and design, as well as policy and protocol development of JPEO-CBRND systems relating to biologics, vaccines and pharmaceuticals.”

“We are honoured by the opportunity to contribute to the DoD mission in the critical CBRN arena.”

As part of the project, the company will bid on different task orders to deliver professional, logistics and medical solutions in support of the DoD across the globe.

Engility will provide programme management and technical expertise to execute the contract, while logistics work is expected to include support associated with development, production, fielding, maintenance and sustainment of a JPEO-CBRND programme of record.

Medical support under the contract will include product concept and design, as well as policy and protocol development of all JPEO-CBRND systems relating to biologics, vaccines and pharmaceuticals.

The medical and logistics contract has a total base period of performance of five years and a one-year option, with a potential additional six-month option.